ãã®ã¬ã€ãã§ãããããš
骚å°è£èŽã€ã³ãã©ã³ããšã¯äœããèœååçµç®ã·ã¹ãã ãšçµç®åã·ã¹ãã ã®éããã©ã®ãããªäººã«åœ¹ç«ã€å¯èœæ§ãããããéåžžã®è©äŸ¡ãæè¡ã®å 容ãMRIã«é¢ããæ³šæç¹ãä¿éºé©çšã®åºæ¬ãæ¥åžžç掻ã§ã®å®çšçãªãã€ã³ãã«ã€ããŠåŠã¹ãŸãã
å®å šã«é¢ããæ³šæ
æ¥ãªèŽåå€åãæ°ããªåŒ·ãããŸããé¡ã®çåŽã®åãå ¥ãã«ããããã®ä»ã®ç¥çµçç¶ãããå Žåã¯ãåŸ ããªãã§ãã ãããä»ããäœããã¹ããã¯ã次ã®å®å šã¬ã€ããã確èªãã ããã ç·æ¥æã¬ã€ãïŒèŽåã»è³é³Žãã»å¹³è¡¡æèŠã®å®å šã¬ã€ãã
骚å°è£èŽã€ã³ãã©ã³ããšã¯äœã§ããïŒ
骚å°è£èŽã€ã³ãã©ã³ãã¯ãé³ãå€è³éãäžè³ã«éãã®ã§ã¯ãªããé è骚ãéãæ¯åã䜿ã£ãŠå è³ïŒèžçïŒãžå±ããããã«èšèšãããèŽèŠã·ã¹ãã ã§ãã å€è³éãäžè³ãããŸãé³ãäŒããããªãå Žåããçæ¹ã®è³ã®èŽåãååã§ãªãããã®åŽããã®é³ã广çã«äœ¿ããªãå Žåã«åœ¹ç«ã€ããšããããŸãã
ã骚åºå®åè£èŽããã€ã¹ïŒBAHDïŒããšããèšèãèãããšããããŸããããã€ãã®å»çæ©é¢ã§ã¯ãBAHDããèœååçµç®ã»çµç®åãå«ãè€æ°ã®éªšå°ã·ã¹ãã ã®ç·ç§°ãšããŠäœ¿ã£ãŠããŸãããã®ã¬ã€ãã§ã¯ãã骚å°è£èŽã€ã³ãã©ã³ãããäž»ãªçšèªãšããŠäœ¿ããäž»ãªã¿ã€ãã以äžã§èª¬æããŸãã
ã·ã¹ãã ã®çš®é¡ïŒèœååçµç®ãäžå¿ã«ãçµç®åãå«ãïŒ
1ïŒèœååçµç®ã€ã³ãã©ã³ãïŒç®èã®äžã«åã蟌ãã¿ã€ãïŒ
èœååçµç®ã·ã¹ãã ã§ã¯ãæ¯åãçã¿åºãéšåãç®èã®äžã«çœ®ããŸããå€éšããã»ããµãŒãé³ãæŸããåã蟌ãŸããéšåãæ¯åãäœã£ãŠéªšãéããŠèžçã«äŒããŸãã ãã®ã·ã¹ãã ã¯ãç®èãè²«ãæ¯æ±ã䜿ãããç®èãä¿ã£ããŸãŸã«ããèšèšã§ããå ·äœçãªé©å¿ã驿 Œåºæºã¯ãFDAã®æ¿èªãŸãã¯èªå¯ãåãã衚瀺å 容ã«ãã£ãŠå®ããããŠããŸãã1
æ€èšãããçç±ïŒçµç®åã·ã¹ãã ãšæ¯ã¹ãŠæ¥åžžçãªç®èã±ã¢ãå°ãªããŠæžã¿ãç®ã«èŠããã¢ãããã¡ã³ãããããŸãããäžæ¹ã§ãããã€ã¹ããšã«ç°ãªãæè¡äžã®ç¹åŸŽããå¿ ãå®ãå¿ èŠãããããã€ã¹ããšã®MRIæ¡ä»¶ããããŸãã1
2ïŒçµç®åïŒã¢ãããã¡ã³ãïŒã·ã¹ãã ïŒç®èãéãã¿ã€ãïŒ
çµç®åã·ã¹ãã ã¯ãç®èãéãå°ããªã¢ãããã¡ã³ãã䜿ããŸããå€éšããã»ããµãŒããã®ã¢ãããã¡ã³ãã«æ¥ç¶ãããæ¯åãé è骚ã«çŽæ¥äŒããæ©æ¢°çãªçµè·¯ãäœããŸãã ããã¯äžéšã®äººã«ãšã£ãŠè¯ãéžæè¢ã«ãªãåŸãŸãããŸããä¿éºãã©ã³ãå°åã«ãã£ãŠä¿éºé©çšãããã€ã¹ãžã®ã¢ã¯ã»ã¹ãç°ãªããããä»ã§ãéèŠãªéžæè¢ã§ãã
éèŠãªãã€ã³ãïŒç®èãéãå°ããªéšäœããããããç¶ç¶çãªç®èã±ã¢ã倧åã§ããåºæ¿ãææã®ãªã¹ã¯ãæžããæ¹æ³ããå»çããŒã ã説æããŸãã
3ïŒæè¡ãããªã骚å°ãªãã·ã§ã³ïŒè©ŠçšãŸãã¯ã€ãªãã®æ¹æ³ïŒ
æè¡ãããªãæ¹æ³ã¯ã广ã詊ããŠã¿ãã®ã«åœ¹ç«ã£ãããæè¡ããŸã é©åã§ãªãå Žåã®ã€ãªããšããŠäœ¿ãããããŸããããšãã°ãå»åŠçãªèš±å¯ãåŸ ã£ãŠããéãªã©ã§ãã ããã€ã¹ã®çš®é¡ã«ãã£ãŠãããããã³ãããœãããã³ãããŸãã¯æ¥çåŒã®è£ çæ¹æ³ã䜿ãããŸããä¿éºé©çšã¯å€§ããç°ãªããäžéšã®ä¿éºã§ã¯æè¡ãããªã骚å°ããã€ã¹ãè£èŽåšãšåæ§ã«æ±ããŸãã
ç°¡åãªæ¯èŒ
| ã·ã¹ãã ã®çš®é¡ | äœãåã蟌ã¿ãŸããïŒ | ç®èã¯ä¿ãããŸããïŒ | ããããæ³šæç¹ |
|---|---|---|---|
| èœååçµç®ã€ã³ãã©ã³ã | æ¯åãçã¿åºãåã蟌ã¿éšåïŒåºå®çšéšæãå«ãïŒ | ã¯ã | ããã€ã¹ããšã®MRIæ¡ä»¶ãããã€ã¹ããšã®æè¡æ¹æ³ãæ¥åžžçãªç®èã±ã¢ãå°ãªã |
| çµç®åïŒã¢ãããã¡ã³ãïŒ | ã€ã³ãã©ã³ãïŒã¢ãããã¡ã³ãïŒç®èãéãæ¯æ±ïŒ | ãããïŒå°ããªç®è貫ééšããïŒ | ç¶ç¶çãªç®èã±ã¢ãå¿ èŠãçŽæ¥æ¥ç¶ãäžéšã®èŽåã¿ã€ãã§åœ¹ç«ã€ããšããã |
| éæè¡å | åã蟌ã¿ãªã | ã¯ã | é·æéã®è£ çšã§ã¯å¿«é©æ§ãäžããããšãããïŒå§è¿«ã»æ¥çïŒãä¿éºé©çšã«å·®ããã |
ã©ã®ãããªäººã«åããŠããŸããïŒ
骚å°ã·ã¹ãã ã¯ã誰ã«ã§ãåãããã«åããã®ã§ã¯ãããŸãããé©å¿ã¯ãèŽåæ€æ»çµæãäœã®æ§é ãç æŽããããŠæ€èšããŠããç¹å®ã®ã·ã¹ãã ã®ããã€ã¹è¡šç€ºã«ãã£ãŠæ±ºãŸããŸãã å€ãã®å»çæ©é¢ã§ã¯ãè³éŒ»åœåç§ã®å€ç§å»ããã°ãã°è³ç§ãŸãã¯ç¥çµè³ç§ã®å°éå»ãšãèŽèŠå°éè·ãååããŠå€æããŸãã2
äŒé³é£èŽ
äŒé³é£èŽãšã¯ãå€è³ãäžè³ãé³ãéãã®ãé£ããäžæ¹ã§ãå è³ïŒèžçïŒã¯æ¯èŒçããŸãæ©èœããŠããå¯èœæ§ãããç¶æ ã§ãã æ ¢æ§çãªè³ã ããè³åãåãã«ããå€è³éã®åœ¢ãäžè³ã®ç¹å®ã®ç æ°ãªã©ã§ãéåžžã®è£èŽåšã䜿ãã«ããããŸãã¯ååãªå¹æããªãå Žåã«ã骚å°ã·ã¹ãã ãæ€èšãããããšããããŸããæ£ç¢ºãªèŽååºæºã¯ãããã€ã¹ã®è¡šç€ºå 容ã«å®ããããŠããŸãã2
æ··åæ§é£èŽ
æ··åæ§é£èŽã¯ãäŒé³æ§ã®èŠçŽ ãšæé³æ§ïŒå è³ïŒã®èŠçŽ ãçµã¿åããã£ããã®ã§ãã骚å°ã·ã¹ãã ã圹ç«ã€ããšããããŸãããé©å¿ã¯èžçã®æ©èœãã©ã®çšåºŠä¿ãããŠãããããããŠã¢ãã«ããšã«ç°ãªãããã€ã¹è¡šç€ºäžã®åºæºã«ãã£ãŠæ±ºãŸããŸãã2
çåŽèŸïŒSSDïŒïŒãé³ã®ã«ãŒãã£ã³ã°ã
äžéšã®éªšå°ã·ã¹ãã ã¯ãèããã«ããåŽã®é³ãæŸããããã骚å°ã§èããã®è¯ãåŽã®èžçã«éãããšã§ãçåŽèŸã«äœ¿ãããšãã§ããŸãã ããã«ãããèããã«ããåŽããæ¥ãé³ã«æ°ã¥ãããããªããããããã·ã£ããŒå¹æããæžããããšãã§ããŸãããã ããé³ã¯æçµçã«çåŽã®èžçã§èããŠãããããéåžžã¯æ¬åœã®æå³ã§ã®äž¡è³ã«ããé³ã®æ¹åæèŠã¯å埩ããŸããã2
é©å¿ãå®å šã«èããããã®åºæ¬
å»çæ©é¢ã§ã¯ãããªãã®èŽåå³ãšç®æšããæ€èšäžã®ç¹å®ã®ããã€ã¹ãã¡ããªãŒã«å¯ŸããFDAæ¿èªãŸãã¯èªå¯ã®é©å¿ã»é©æ Œåºæºãšç §ããåãããŠå€æããå¿ èŠããããŸããã€ã³ã¿ãŒãããã§æ°å€ã®åºæºãèŠãããŠãããããæ£ç¢ºãªã¢ãã«ã®è¡šç€ºå å®¹ã«æç¢ºã«çµã³ã€ããŠããªãéãããã®ããã€ã¹åºæã®æ å ±ãšããŠæ éã«åãåã£ãŠãã ããã
éåžžã®è©äŸ¡ã«å«ãŸãããã®
1ïŒèšºå¯ãšè³ã®èšºå¯
è³éŒ»åœåç§ã®å»çè ãç æŽã確èªããè³ã蚺å¯ããŠãæŽ»åæ§ã®ææããã€ã³ãã©ã³ããæ±ºããåã«æ²»çã»æè¡ã§å¯ŸåŠãã¹ãç æ°ãªã©ãæ²»çå¯èœãªåå ããªããã調ã¹ãŸãã å Žåã«ãã£ãŠã¯ãæè¡èšç»ã®ããã«ç»åæ€æ»ãè¡ãããŸãã
2ïŒè©³ããèŽåè©äŸ¡
èŽèŠå°éè·ã¯éåžžãæ°å°ã»éªšå°ã®éŸå€ãšãããšã°ã®èãåããæž¬å®ããŸããçåŽèŸã®å€æã§ã¯ãéšé³äžã§ã®èããæ¹ããé³ã®ã«ãŒãã£ã³ã°ãæ¥åžžç掻ã®ç®æšã«åããã©ãããè©äŸ¡ãããããšããããããŸãã
3ïŒã詊èŽãã®äœéšïŒå¯èœãªå ŽåïŒ
å€ãã®å»çæ©é¢ã§ã¯ãããããã³ãããœãããã³ããªã©ã®éæè¡åã®æ¹æ³ã§éªšå°ã詊ãããšãã§ããŸããããã¯åã蟌ã¿åã·ã¹ãã ãå®å šã«åçŸãããã®ã§ã¯ãããŸããããæåŸ ãçŸå®çã«æŽããçžè«ããªããæææ±ºå®ããå©ãã«ãªããŸãã
MRIã«ã€ããŠç¥ã£ãŠããããããšïŒããã€ã¹ããšã«ç°ãªããŸãïŒ
MRIã®å®å šæ§ã¯ãããã€ã¹ãšã¢ãã«ã«ãã£ãŠç°ãªããŸããå€ãã®åã蟌ã¿åèŽèŠã·ã¹ãã ã¯MRIæ¡ä»¶ä»ã察å¿ã§ãå®ããããæ¡ä»¶ã®ããšã§MRIãå¯èœãªå ŽåããããŸãã ãã®æ¡ä»¶ã¯ãç£ç³ã®èšèšãæ€æ»ã®çš®é¡ãMRIã®ç£å ŽåŒ·åºŠã«ãã£ãŠå€ããããšããããŸãã
MRIãåããåã«
- äºçŽåã«ãç»åæ€æ»ã®æ åœããŒã ãžåã蟌ã¿åèŽèŠããã€ã¹ãããããšãäŒããŠãã ããã
- å蚺æã«ã¯ã€ã³ãã©ã³ãã«ãŒãããŸãã¯ããã€ã¹æ å ±ãæåããŠãã ããã
- èªåã®ããã€ã¹ãã¡ããªãŒã«å¯Ÿå¿ããMRIã¬ã€ãã©ã€ã³ã«åŸã£ãŠãã ãããç°ãªã2ã€ã®ã·ã¹ãã ã§åãã«ãŒã«ã ãšèããŠã¯ãããŸããã
åèæç®ã«ã¯ããããã€ã¹ããšã®MRIã«ãŒã«ããã©ã®ãããªãã®ãã瀺ããããã¡ãŒã«ãŒã®MRIã¬ã€ãææžã®äŸãæ²èŒããŠããŸãã3
æè¡ãšè£ çšéå§ã®äžè¬çãªæµãïŒè©³çްã¯ç°ãªããŸãïŒ
å€ãã®éªšå°ã€ã³ãã©ã³ãã¯æ¥åž°ãæè¡ã§è¡ãããŸãããå ·äœçãªæ¹æ³ã¯ã·ã¹ãã ã®çš®é¡ãšäœã®æ§é ã«ãã£ãŠç°ãªããŸããäžè¬çã«ã¯æ¬¡ã®éãã§ãã
- çµç®åã·ã¹ãã ã§ã¯ãã€ã³ãã©ã³ããšç®èãéãã¢ãããã¡ã³ããèšçœ®ããŸãã
- èœååçµç®ã·ã¹ãã ã§ã¯ãç®èãä¿ã£ããŸãŸããã®äžã«åã蟌ã¿éšåã眮ããŸãã
æè¡åŸã¯ãå€éšããã»ããµãŒãè£ çããŠäœåãããåã«ãéåžžã¯æ²»çæéããããŸããå»çããŒã ããã·ã¹ãã ã®çš®é¡ãšæ²»ãæ¹ã«å¿ããã¹ã±ãžã¥ãŒã«ã説æããŸãã
ä¿éºé©çšïŒç±³åœïŒïŒäžè¬çã«èšããããšãšãç°ãªãããš
ä¿éºé©çšã¯ãæãæ··ä¹±ããããç¹ã®ã²ãšã€ã§ããéèŠãªã®ã¯ãäžéšã®åã蟌ã¿å骚å°ã·ã¹ãã ããä¿éºäŒç€Ÿã«ãã£ãŠãè£èŽåšãã§ã¯ãªãè£ç¶Žè£ 眮ãŸãã¯åã蟌ã¿åããã€ã¹ãšããŠæ±ãããããšãããããã®åé¡ãä¿éºé©çšã®æµãã«åœ±é¿ãããšããç¹ã§ãã4
- MedicareïŒMedicareã§ã¯ãéåžžãè£èŽåšïŒå€ãã®å Žåã¯éé©çšïŒãšãäžå®ã®æ¡ä»¶ã§é©çšãšãªãå¯èœæ§ãããäžéšã®åã蟌ã¿åèŽèŠè£ç¶Žè£ 眮ãåºå¥ããŠããŸããå»çæ©é¢ã®æ¿èªæ åœããŒã ããããªãã®ã±ãŒã¹ãšããã€ã¹ã®çš®é¡ã«äœãåœãŠã¯ãŸããã確èªããå©ãã«ãªããŸãã4
- MedicaidïŒé©çšç¯å²ã¯å·ã幎霢局ã«ãã£ãŠç°ãªããäºåæ¿èªãå¿ èŠãªããšããããããŸãã
- æ°éä¿éºïŒä¿éºå 容ã¯å€§ããç°ãªããŸããããçš®é¡ã®ã€ã³ãã©ã³ãã¯æ¯èŒçæ¿èªããããããå¥ã®çš®é¡ã¯é£ããããšããããŸãããã®ãããäžéšã®ç¶æ³ã§ã¯çµç®åã·ã¹ãã ãä»ãªãéžæè¢ãšããŠéèŠã§ãã
å®çšçãªãã³ã
å»çæ©é¢ã«ãç³è«ããŠããæ£ç¢ºãªããã€ã¹ã®çš®é¡ïŒã€ã³ãã©ã³ãã®ã¿ã€ãïŒãäºå®ããŠããè«æ±ã³ãŒããæåºããèšåºè³æã確èªããŠãã ããããããè£èŽåšããšããŠåŽäžãããå Žåãç°è°ç³ãç«ãŠã§ã¯ããã®ã·ã¹ãã ãããªãã®ä¿éºã§åã蟌ã¿åè£ç¶Žè£ 眮ãšããŠåé¡ããããã©ãããéèŠã«ãªãããšããããŸãã
骚å°ã·ã¹ãã ãšæ®ãã
æ¥åžžã®ã±ã¢ïŒã·ã¹ãã ããšã«ç°ãªããŸãïŒ
- çµç®åïŒã¢ãããã¡ã³ãïŒïŒåºæ¿ãææã®ãªã¹ã¯ãæžããããã«ãã¢ãããã¡ã³ãåšå²ã®ç®èãã©ãæž æœã«ä¿ã€ãã«ã€ããŠãå ·äœçãªèª¬æãåããŸãã
- èœååçµç®ïŒéåžžã®ç®èã®æž æœã±ã¢ã«è¿ãããšãå€ãã§ãããç£ç³ãããã»ããµãŒã®äœçœ®ãå¿«é©ãã®èª¿æŽã«ã€ããŠã¯ãã·ã¹ãã ãç£æ°çµåã䜿ãå Žåã«æ¡å ãå¿ èŠã§ãã
æ°Žãã¹ããŒããç¡ç
äžè¬çã«ã¯ãåã蟌ã¿éšåã¯ãã®ãŸãŸã«ããã·ã£ã¯ãŒãæ°Žæ³³ã®ãšãã«ã¯å€éšããã»ããµãŒãå€ããŸãããã ããç¹å®ã®ããã»ããµãŒã鲿°Žå¯Ÿå¿ããŠããå Žåã¯äŸå€ããããŸãã ã³ã³ã¿ã¯ãã¹ããŒãã§ã¯ãéåžžãããã»ããµãŒãå€ããŠåã蟌ã¿éšäœãä¿è·ããããå§ããããŸãããæé©ãªæç€ºã¯ã€ã³ãã©ã³ãã®çš®é¡ã掻åå 容ã«ãã£ãŠç°ãªããŸãã
ãŸãšã
骚å°è£èŽã€ã³ãã©ã³ãã¯ãéåžžã®è³ã®é³ã®éãéãããŸãåããªããšãããé³ãçåŽããå察åŽãžéãå¿ èŠããããšãã«ãé³ãžã®ã¢ã¯ã»ã¹ãæ¹åããå¯èœæ§ããããŸãã ã©ã®ã·ã¹ãã ããæé©ããã¯ãããªãã®èŽåã¿ã€ããç®æšãäœã®æ§é ããããŠããã€ã¹è¡šç€ºã«å ããMRIã®å¿ èŠæ§ãä¿éºé©çšãšãã£ãçŸå®çãªèŠçŽ ã«ãã£ãŠæ±ºãŸããŸãã
æãå®å šãªæ¬¡ã®ã¹ãããã¯ã骚å°ã·ã¹ãã ãæ¥åžžçã«æ±ã£ãŠããè³éŒ»åœåç§å€ç§å»ãšèŽèŠå°éè·ã«ããååè©äŸ¡ãåããããšã§ãã
ãããã質å
次ã®ã¹ãããïŒã€ã³ãã©ã³ãã«è©³ããè©äŸ¡ãåãã
骚å°ã·ã¹ãã ãæ€èšããŠããå Žåãæã圹ç«ã€æ¬¡ã®ã¹ãããã¯ããããã®ããã€ã¹ãæ¥åžžçã«æ±ãè³éŒ»åœåç§å€ç§å»ãšèŽèŠå°éè·ã«ãã飿ºããè©äŸ¡ãåããããšã§ãã
åèæç®
ç§ãã¡ã¯FDAã®èŠçŽã»è¡šç€ºå 容ãä¿éºè ã®ã¬ã€ãã³ã¹ãªã©ãäžæ¬¡æ å ±ãåªå ããŠããŸããèŽååºæºã®æ°å€ãMRIæ¡ä»¶ãªã©ãããã€ã¹åºæã®æ å ±ã«ã€ããŠã¯ã å¿ ããå»çæ©é¢ãå§ããæ£ç¢ºãªã¢ãã«ã®è¡šç€ºå 容ãšMRIã¬ã€ãã³ã¹ãåªå ããŠãã ããã
- U.S. Food & Drug Administration (FDA). De Novo Classification Summary PDF for an active transcutaneous bone conduction implant system (example FDA primary source). 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã FDA PDFã
- å»çæ©é¢ãå§ããç¹å®ã®ããã€ã¹ãã¡ããªãŒã«å¯Ÿããã¡ãŒã«ãŒã®é©å¿ã»éžå®ã¬ã€ãïŒã¢ãã«åºæïŒãããã§ã¯ãæ°å€ã«ãã驿 Œåºæºãæ£ç¢ºãªã¢ãã«ã®è¡šç€ºå 容ã«çµã³ã€ããŠããå¿ èŠãããããšã匷調ããããã«çšããŠããŸãã2026幎1æ31æ¥ã¢ã¯ã»ã¹ã
- ç¹å®ã®åã蟌ã¿éšåããã³ããã»ããµãŒã«å¯Ÿããã¡ãŒã«ãŒã®MRIã¬ã€ãã©ã€ã³ïŒã¢ãã«åºæïŒãããã§ã¯ãMRIæ¡ä»¶ä»ã察å¿ã®èŠä»¶ãããã€ã¹ããšã«ç°ãªãããšã匷調ããããã«çšããŠããŸãã2026幎1æ31æ¥ã¢ã¯ã»ã¹ã
- Centers for Medicare & Medicaid Services (CMS). Medicare Coverage Database (coverage policies and related guidance; implantable hearing prostheses vary by context). 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã CMS MCDã
- Dahm V, Baumgartner W-D, Liepins R, Arnoldner C. A consensus statement on bone conduction implants (BCI). Audiology Research. 2022. 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã https://doi.org/10.3390/audiolres12020030ã
- Sprinzl GM, Wolf-Magele A. The Bonebridge bone conduction hearing implant: indication criteria, surgery and a systematic review of the literature. Clinical Otolaryngology. 2016. 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã https://doi.org/10.1111/coa.12484ã
- Systematic review: audiological indication criteria for bone conduction hearing devices and active middle ear implants. 2021. 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã ScienceDirect recordã
- U.S. Food & Drug Administration (FDA). Premarket Notification (510(k)) Database (use to locate device entries and, when available, labeling/IFU references). 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã FDA 510(k) databaseã
- U.S. Food & Drug Administration (FDA). De Novo Database (decision summaries for De Novo devices). 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã FDA De Novo databaseã
- National Library of Medicine (NLM). AccessGUDID (Global Unique Device Identification Database; helpful for verifying identifiers and basic device fields). 2026幎1æ31æ¥ã¢ã¯ã»ã¹ã https://accessgudid.nlm.nih.gov/ã
ãã®èšäºã¯åœ¹ã«ç«ã¡ãŸãããïŒ
å 責äºé ïŒãã®å 容ã¯äžè¬çãªæè²ç®çã®ã¿ãæå³ãããã®ã§ãããå°éçãªå»çå©èšã蚺æãæ²»çã®ä»£ããã«ã¯ãªããŸãããå¥åº·ç¶æ ã«ã€ããŠçåãããå Žåã¯ãå¿ ãå»åž«ãŸãã¯è³æ Œã®ããå»çå°éè·ã«çžè«ããŠãã ããã